Blood tumor mutational burden and dynamic changes in circulating tumor DNA predict response to pembrolizumab treatment in advanced non-small cell lung cancer

血液肿瘤突变负荷和循环肿瘤 DNA 的动态变化可预测晚期非小细胞肺癌对派姆单抗治疗的反应